CA2357037A1 - Optical sorting method - Google Patents
Optical sorting method Download PDFInfo
- Publication number
- CA2357037A1 CA2357037A1 CA002357037A CA2357037A CA2357037A1 CA 2357037 A1 CA2357037 A1 CA 2357037A1 CA 002357037 A CA002357037 A CA 002357037A CA 2357037 A CA2357037 A CA 2357037A CA 2357037 A1 CA2357037 A1 CA 2357037A1
- Authority
- CA
- Canada
- Prior art keywords
- optical properties
- gene product
- genetic
- genetic element
- genetic elements
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1075—Isolating an individual clone by screening libraries by coupling phenotype to genotype, not provided for in other groups of this subclass
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1062—Isolating an individual clone by screening libraries mRNA-Display, e.g. polypeptide and encoding template are connected covalently
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Holo Graphy (AREA)
- Enzymes And Modification Thereof (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The invention describes a method for isolating one or more genetic elements encoding a gene product having a desired activity, comprising the steps of: (a) compartmentalising genetic elements into microcapsules; (b) expressing t he genetic elements to produce their respective gene products within the microcapsules; (c) sorting the genetic elements which produce the gene produ ct having the desired activity using a change in the optical properties of the genetic elements. The invention enables the in vitro evolution of nucleic acids and proteins by repeated mutagenesis and iterative applications of the method of the invention.
Claims (44)
1. A method for isolating one or more genetic elements encoding a gene product having a desired activity the expression of which may result, directly or indirectly, in the modification of an optical property of a genetic element encoding the gene product, comprising the steps of:
(a) compartmentalising genetic elements into microcapsules;
(b) expressing the genetic elements to produce their respective gene products within the microcapsules;
(c) sorting the genetic elements which produce the gene product(s) having the desired activity according to a change in the optical properties of the genetic elements.
(a) compartmentalising genetic elements into microcapsules;
(b) expressing the genetic elements to produce their respective gene products within the microcapsules;
(c) sorting the genetic elements which produce the gene product(s) having the desired activity according to a change in the optical properties of the genetic elements.
2. A method according to claim 1, wherein in step (b) the activity of the desired gene product within the microcapsule results, directly or indirectly, in the modification of the genetic element encoding the gene product to enable the isolation of the genetic element.
3. A method according to claim 2, wherein in the modification of the genetic element within the microcapsule induces a change in its optical properties.
4. A method according to claim 2, wherein the modification of the genetic element enables it to be further modified outside the microcapsule so as to induce a change in its optical properties.
5. A method according to claim 2, wherein a part of the genetic element is a ligand and the desired gene product within the microcapsule binds, directly or indirectly, to said ligand to enable the isolation of the genetic element.
6. A method according to claim 5, wherein the ligand is also encoded by the genetic element.
7. A method according to claim 2, wherein a part of the genetic element is a substrate and the activity of the desired gene product within the microcapsule results, directly or indirectly, in the conversion of said substrate into a product which remains part of the genetic element and enables its isolation.
8. A method according to claim 2, wherein the product of the activity of the desired gene product within the microcapsule results, directly or indirectly, in the generation of a product which is subsequently complexed with the genetic element and enables its isolation.
9. A method according to any preceding claim wherein the activity of the desired gene product within the microcapsule results, directly or indirectly, in the alteration of the expression of a second gene within the compartment and the activity of the product of the said second gene enables the isolation of the genetic element using a change in the optical properties of the genetic element.
10. A method according to claim 1, wherein step (b) comprises:
expressing the genetic elements to produce their respective gene products within the microcapsules, linking the gene products to the genetic elements encoding them and isolating the complexes thereby formed.
expressing the genetic elements to produce their respective gene products within the microcapsules, linking the gene products to the genetic elements encoding them and isolating the complexes thereby formed.
11. A method according to claim 10, wherein in step (c) the complexes are directly sorted based on their changed optical properties to isolate genetic elements encoding a gene product having the desired activity.
12. A method according to claim 10, wherein in step (c) the complexes are further reacted to induce a conditional change in optical properties of the genetic element dependent on the presence of gene products with the desired activity in the complex.
13. A method according to claim 10, wherein the complexes are subjected to a further compartmentalisation step in order to isolate the genetic elements encoding a gene product having the desired activity.
14. A method according to claim 1, wherein the change in optical properties of the genetic element is due to binding of a gene product with distinctive optical properties to the genetic element.
15. A method according to claim 1, wherein the change in optical properties of the genetic element is due to binding of a ligand with distinctive optical properties by the gene product.
16. A method according to claim 1, wherein the change in optical properties of the genetic element is due to a change in the optical properties of the gene product when bound to ligand.
17. A method according to claim 1, wherein the change in optical properties of the genetic element is due to a change in the optical properties of the ligand when bound by the gene product.
18. A method according to claim 1, wherein the change in optical properties of the genetic element is due to a change in the optical properties of both ligand and gene product on binding.
19. A method according to claim 1, wherein the change in optical properties of the genetic element is due to the different optical properties of the substrate and the product of the reaction being selected.
20. A method according to claim 1, wherein both substrate and product have similar optical properties, but only the product, and not the substrate of the reaction being selected binds to, or reacts with, the genetic element, thereby changing the optical properties of the genetic element.
21. A method according to claim 1, wherein further reagents specifically bind to, or specifically react with. the product (and not the substrate) attached to the genetic element, thereby altering the optical properties of the genetic element.
22. A method according to any preceding claim, wherein a non-desired activity of a gene product results in a change in the optical properties of the genetic element which is distinct from that resulting from the desired activity.
23. A method according to claim 22, wherein the optical change resulting from the non-desired activity is used to negatively select the genetic elements.
24. A method according to claim 22, wherein negative selection is combined with positive selection to improve reaction specificity.
25. A method according to claim 24, wherein the improved reaction specificity is an improvement in binding specificity.
26. A method according to claim 24, wherein the improved reaction specificity is an improvement in regio- and/or stereo-selectivity for substrate and/or product.
27. A method according to any preceding claim, wherein the genetic elements are isolated from a library of genetic elements encoding a repertoire of gene products.
28. A method according to any preceding claim, wherein each genetic element encodes more two or more genes and each gene product must have a desired activity in order for the optical properties of the genetic element to be modified to enable them to be sorted.
29. A method according to any preceding claim, wherein each genetic element encodes two or more genes and the gene products must bind to each other in the microcapsule in order for the optical properties of the genetic element to be modified and the genetic elements sorted.
30. A method according to any preceding claim further comprising the additional step of:
(d) introducing one or more mutations into the genetic element(s) isolated in step (c).
(d) introducing one or more mutations into the genetic element(s) isolated in step (c).
31. A method according to any preceding claim further comprising iteratively repeating one or more of steps (a) to (d).
32. A method according to any preceding claim further comprising amplifying the genetic elements.
33. A method according to claim 1, wherein microencapsulation is achieved by forming a water-in-oil emulsion of the aqueous solution in an oil-based medium.
34. A method according to claim 1, wherein the genetic element comprises the gene attached to a microbead.
35. A method according to claim 1, wherein the microbead is nonmagnetic, magnetic or paramagnetic.
36. A method according to claim 1, wherein the genetic elements are sorted by detection of a change in their fluorescence.
37. A method according to claim 36, wherein the sorting of genetic elements is performed using a fluorescence activated cell sorter (FACS) (or similar device).
38. A method according to claim 36, wherein the different fluorescence properties of the substrate and the product are due to fluorescence resonance energy transfer (FRET).
39. A method according to any preceding claim, wherein the internal environment of the microcapsules is modified by the addition of one or more reagents to the oil phase.
40. A method according to any preceding claim, wherein genetic elements modified directly or indirectly by the activity of the desired gene product are further modified by Tyramide Signal Amplification (TSAT TM; NEN), resulting directly or indirectly in a change in the optical properties of said genetic elements thereby enabling their separation.
41. A product when isolated according to the method of any preceding claim.
42. A method for preparing a gene product, comprising the steps of:
(a) preparing a genetic element encoding the gene product;
(b) compartmentalising genetic elements into microcapsules;
(c) expressing the genetic elements to produce their respective gene products within the microcapsules;
(d) sorting the genetic elements which produce the gene product(s) having the desired activity using a change in their optical properties; and (e) expressing the gene product having the desired activity.
(a) preparing a genetic element encoding the gene product;
(b) compartmentalising genetic elements into microcapsules;
(c) expressing the genetic elements to produce their respective gene products within the microcapsules;
(d) sorting the genetic elements which produce the gene product(s) having the desired activity using a change in their optical properties; and (e) expressing the gene product having the desired activity.
43. A method for screening a compound or compounds capable of modulating the activity of a gene product, comprising the steps of:
(a) preparing a repertoire of genetic elements encoding gene product;
(b) compartmentalising the genetic elements into microcapsules;
(c) expressing the genetic elements to produce their respective gene products within the microcapsules;
(d) sorting the genetic elements which produce the gene product(s) having the desired activity using a change in their optical properties; and (e) contacting a gene product having the desired activity with the compound or compounds and monitoring the modulation of an activity of the gene product by the compound or compounds.
(a) preparing a repertoire of genetic elements encoding gene product;
(b) compartmentalising the genetic elements into microcapsules;
(c) expressing the genetic elements to produce their respective gene products within the microcapsules;
(d) sorting the genetic elements which produce the gene product(s) having the desired activity using a change in their optical properties; and (e) contacting a gene product having the desired activity with the compound or compounds and monitoring the modulation of an activity of the gene product by the compound or compounds.
44. A method for preparing a compound or compounds comprising the steps of:
(a) providing a synthesis protocol wherein at least one step is facilitated by a polypeptide;
(b) preparing genetic elements encoding variants of the polypeptide which facilitates this step;
(c) compartmentalising the genetic elements into microcapsules;
(d) expressing the genetic elements to produce their respective gene products within the microcapsules;
(e) sorting the genetic elements which produce polypeptide gene product(s) having the desired activity using a change in their optical properties; and (f) preparing the compound or compounds using the polypeptide gene product identified in (e) to facilitate the relevant step of the synthesis.
(a) providing a synthesis protocol wherein at least one step is facilitated by a polypeptide;
(b) preparing genetic elements encoding variants of the polypeptide which facilitates this step;
(c) compartmentalising the genetic elements into microcapsules;
(d) expressing the genetic elements to produce their respective gene products within the microcapsules;
(e) sorting the genetic elements which produce polypeptide gene product(s) having the desired activity using a change in their optical properties; and (f) preparing the compound or compounds using the polypeptide gene product identified in (e) to facilitate the relevant step of the synthesis.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002584933A CA2584933A1 (en) | 1999-01-07 | 2000-01-06 | Optical sorting method |
CA002479551A CA2479551A1 (en) | 1999-01-07 | 2000-01-06 | Optical sorting method |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9900298.2 | 1999-01-07 | ||
GBGB9900298.2A GB9900298D0 (en) | 1999-01-07 | 1999-01-07 | Optical sorting method |
PCT/GB2000/000030 WO2000040712A1 (en) | 1999-01-07 | 2000-01-06 | Optical sorting method |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002479551A Division CA2479551A1 (en) | 1999-01-07 | 2000-01-06 | Optical sorting method |
CA002584933A Division CA2584933A1 (en) | 1999-01-07 | 2000-01-06 | Optical sorting method |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2357037A1 true CA2357037A1 (en) | 2000-07-13 |
CA2357037C CA2357037C (en) | 2012-12-11 |
Family
ID=10845700
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002479551A Abandoned CA2479551A1 (en) | 1999-01-07 | 2000-01-06 | Optical sorting method |
CA2357037A Expired - Lifetime CA2357037C (en) | 1999-01-07 | 2000-01-06 | Optical sorting method |
CA002584933A Abandoned CA2584933A1 (en) | 1999-01-07 | 2000-01-06 | Optical sorting method |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002479551A Abandoned CA2479551A1 (en) | 1999-01-07 | 2000-01-06 | Optical sorting method |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002584933A Abandoned CA2584933A1 (en) | 1999-01-07 | 2000-01-06 | Optical sorting method |
Country Status (11)
Country | Link |
---|---|
US (6) | US6808882B2 (en) |
EP (4) | EP1905828B1 (en) |
JP (5) | JP4851008B2 (en) |
AT (3) | ATE366307T1 (en) |
AU (1) | AU781217B2 (en) |
CA (3) | CA2479551A1 (en) |
DE (2) | DE60043289D1 (en) |
DK (2) | DK1522581T3 (en) |
ES (4) | ES2333844T3 (en) |
GB (1) | GB9900298D0 (en) |
WO (1) | WO2000040712A1 (en) |
Families Citing this family (208)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69826697T2 (en) | 1997-07-07 | 2006-02-16 | Medical Research Council | IN VITRO SELECTION METHOD |
US6231521B1 (en) | 1998-12-17 | 2001-05-15 | Peter Zoth | Audiological screening method and apparatus |
GB9900298D0 (en) * | 1999-01-07 | 1999-02-24 | Medical Res Council | Optical sorting method |
US6432290B1 (en) | 1999-11-26 | 2002-08-13 | The Governors Of The University Of Alberta | Apparatus and method for trapping bead based reagents within microfluidic analysis systems |
CA2290731A1 (en) | 1999-11-26 | 2001-05-26 | D. Jed Harrison | Apparatus and method for trapping bead based reagents within microfluidic analysis system |
GB0022458D0 (en) * | 2000-09-13 | 2000-11-01 | Medical Res Council | Directed evolution method |
FR2816943B1 (en) * | 2000-11-22 | 2004-02-13 | Inst Nat Sante Rech Med | BIOTIN DERIVATIVES, METHODS OF MAKING SAME AND USES THEREOF AS VECTORS |
GB0114854D0 (en) * | 2001-06-18 | 2001-08-08 | Medical Res Council | Selective gene amplification |
GB0115841D0 (en) | 2001-06-28 | 2001-08-22 | Medical Res Council | Ligand |
GB0127564D0 (en) * | 2001-11-16 | 2002-01-09 | Medical Res Council | Emulsion compositions |
US9321832B2 (en) | 2002-06-28 | 2016-04-26 | Domantis Limited | Ligand |
JP2006507921A (en) * | 2002-06-28 | 2006-03-09 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | Method and apparatus for fluid dispersion |
US20060002935A1 (en) | 2002-06-28 | 2006-01-05 | Domantis Limited | Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor |
ATE488586T1 (en) | 2002-09-06 | 2010-12-15 | Isogenica Ltd | IN VITRO PEPTIDE EXPRESSION BANK |
GB0221053D0 (en) * | 2002-09-11 | 2002-10-23 | Medical Res Council | Single-molecule in vitro evolution |
AU2003275940A1 (en) * | 2002-10-31 | 2004-05-25 | Chemometec A/S | A method for assessment of particles |
KR101216828B1 (en) | 2002-12-30 | 2013-01-04 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | Methods and apparatus for pathogen detection and analysis |
WO2004069849A2 (en) * | 2003-01-29 | 2004-08-19 | 454 Corporation | Bead emulsion nucleic acid amplification |
US7575865B2 (en) * | 2003-01-29 | 2009-08-18 | 454 Life Sciences Corporation | Methods of amplifying and sequencing nucleic acids |
US7041481B2 (en) | 2003-03-14 | 2006-05-09 | The Regents Of The University Of California | Chemical amplification based on fluid partitioning |
GB0307403D0 (en) * | 2003-03-31 | 2003-05-07 | Medical Res Council | Selection by compartmentalised screening |
GB0307428D0 (en) | 2003-03-31 | 2003-05-07 | Medical Res Council | Compartmentalised combinatorial chemistry |
US20060078893A1 (en) | 2004-10-12 | 2006-04-13 | Medical Research Council | Compartmentalised combinatorial chemistry by microfluidic control |
AU2004229440B2 (en) | 2003-04-10 | 2010-08-12 | President And Fellows Of Harvard College | Formation and control of fluidic species |
US20040265835A1 (en) * | 2003-06-30 | 2004-12-30 | Lemaster David M. | Method of sorting vesicle-entrapped, coupled nucleic acid-protein displays |
JP5183063B2 (en) | 2003-07-05 | 2013-04-17 | ザ ジョンズ ホプキンス ユニバーシティ | Methods and compositions for detection and enumeration of genetic variations |
EP1658133A1 (en) | 2003-08-27 | 2006-05-24 | President And Fellows Of Harvard College | Electronic control of fluidic species |
GB0325653D0 (en) | 2003-11-03 | 2003-12-10 | Medical Res Council | CST emulsions |
EP1691792A4 (en) * | 2003-11-24 | 2008-05-28 | Yeda Res & Dev | Compositions and methods for in vitro sorting of molecular and cellular libraries |
CA2553833C (en) | 2004-01-28 | 2012-10-02 | 454 Corporation | Nucleic acid amplification with continuous flow emulsion |
US20050221339A1 (en) | 2004-03-31 | 2005-10-06 | Medical Research Council Harvard University | Compartmentalised screening by microfluidic control |
US7799553B2 (en) * | 2004-06-01 | 2010-09-21 | The Regents Of The University Of California | Microfabricated integrated DNA analysis system |
US7081227B2 (en) * | 2004-06-07 | 2006-07-25 | The Reagents Of The University Of California | Amphiphilic mediated sample preparation for micro-flow cytometry |
US9477233B2 (en) | 2004-07-02 | 2016-10-25 | The University Of Chicago | Microfluidic system with a plurality of sequential T-junctions for performing reactions in microdroplets |
CN101073002B (en) | 2004-09-15 | 2012-08-08 | 英特基因有限公司 | Microfluidic devices |
CN101724071A (en) | 2004-10-08 | 2010-06-09 | 杜门蒂斯有限公司 | Single domain antibodies against TNFRl and methods of use therefor |
US7968287B2 (en) | 2004-10-08 | 2011-06-28 | Medical Research Council Harvard University | In vitro evolution in microfluidic systems |
EP2272983A1 (en) | 2005-02-01 | 2011-01-12 | AB Advanced Genetic Analysis Corporation | Reagents, methods and libraries for bead-based sequencing |
US20070054119A1 (en) * | 2005-03-04 | 2007-03-08 | Piotr Garstecki | Systems and methods of forming particles |
US9039273B2 (en) | 2005-03-04 | 2015-05-26 | President And Fellows Of Harvard College | Method and apparatus for forming multiple emulsions |
WO2006099579A2 (en) * | 2005-03-16 | 2006-09-21 | Applera Corporation | Compositions and methods for clonal amplification and analysis of polynucleotides |
PT1948816E (en) * | 2005-10-24 | 2012-03-19 | Univ Johns Hopkins | Improved methods for beaming |
WO2007081387A1 (en) | 2006-01-11 | 2007-07-19 | Raindance Technologies, Inc. | Microfluidic devices, methods of use, and kits for performing diagnostics |
DE602007009811D1 (en) * | 2006-01-27 | 2010-11-25 | Harvard College | COALESCENCE FLUIDER DROPLET |
US7749365B2 (en) | 2006-02-01 | 2010-07-06 | IntegenX, Inc. | Optimized sample injection structures in microfluidic separations |
AU2007211829C9 (en) | 2006-02-01 | 2013-07-11 | Cephalon Australia Pty Ltd | Domain antibody construct |
WO2008030631A2 (en) | 2006-02-03 | 2008-03-13 | Microchip Biotechnologies, Inc. | Microfluidic devices |
EP1989529A4 (en) | 2006-02-13 | 2010-09-01 | Agency Science Tech & Res | Method of processing a biological and/or chemical sample |
US7766033B2 (en) | 2006-03-22 | 2010-08-03 | The Regents Of The University Of California | Multiplexed latching valves for microfluidic devices and processors |
EP2047910B1 (en) | 2006-05-11 | 2012-01-11 | Raindance Technologies, Inc. | Microfluidic device and method |
US9562837B2 (en) | 2006-05-11 | 2017-02-07 | Raindance Technologies, Inc. | Systems for handling microfludic droplets |
US20080076909A1 (en) * | 2006-06-30 | 2008-03-27 | Applera Corporation | Emulsion pcr and amplicon capture |
EP3536396B1 (en) | 2006-08-07 | 2022-03-30 | The President and Fellows of Harvard College | Fluorocarbon emulsion stabilizing surfactants |
US8841116B2 (en) | 2006-10-25 | 2014-09-23 | The Regents Of The University Of California | Inline-injection microdevice and microfabricated integrated DNA analysis system using same |
EP2109666A4 (en) | 2007-02-05 | 2011-09-14 | Integenx Inc | Microfluidic and nanofluidic devices, systems, and applications |
WO2008097559A2 (en) | 2007-02-06 | 2008-08-14 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
US9029085B2 (en) | 2007-03-07 | 2015-05-12 | President And Fellows Of Harvard College | Assays and other reactions involving droplets |
WO2008121342A2 (en) * | 2007-03-28 | 2008-10-09 | President And Fellows Of Harvard College | Emulsions and techniques for formation |
US8592221B2 (en) | 2007-04-19 | 2013-11-26 | Brandeis University | Manipulation of fluids, fluid components and reactions in microfluidic systems |
US8691164B2 (en) * | 2007-04-20 | 2014-04-08 | Celula, Inc. | Cell sorting system and methods |
US7883265B2 (en) * | 2007-06-01 | 2011-02-08 | Applied Biosystems, Llc | Devices, systems, and methods for preparing emulsions |
WO2009015296A1 (en) | 2007-07-24 | 2009-01-29 | The Regents Of The University Of California | Microfabricated dropley generator |
WO2009021215A1 (en) * | 2007-08-09 | 2009-02-12 | Celula, Inc. | Methods and devices for correlated, multi-parameter single cell measurements and recovery of remnant biological material |
WO2009067743A1 (en) | 2007-11-27 | 2009-06-04 | Human Genetic Signatures Pty Ltd | Enzymes for amplification and copying bisulphite modified nucleic acids |
EP2222709B1 (en) | 2007-11-30 | 2016-11-23 | Glaxo Group Limited | Antigen-binding constructs |
US9797010B2 (en) | 2007-12-21 | 2017-10-24 | President And Fellows Of Harvard College | Systems and methods for nucleic acid sequencing |
KR20110030415A (en) | 2008-01-22 | 2011-03-23 | 인터젠엑스 인크. | Universal sample preparation system and use in an integrated analysis system |
EP2315629B1 (en) | 2008-07-18 | 2021-12-15 | Bio-Rad Laboratories, Inc. | Droplet libraries |
US20110218123A1 (en) | 2008-09-19 | 2011-09-08 | President And Fellows Of Harvard College | Creation of libraries of droplets and related species |
US8951939B2 (en) | 2011-07-12 | 2015-02-10 | Bio-Rad Laboratories, Inc. | Digital assays with multiplexed detection of two or more targets in the same optical channel |
US8633015B2 (en) | 2008-09-23 | 2014-01-21 | Bio-Rad Laboratories, Inc. | Flow-based thermocycling system with thermoelectric cooler |
WO2011120020A1 (en) | 2010-03-25 | 2011-09-29 | Quantalife, Inc. | Droplet transport system for detection |
US9417190B2 (en) | 2008-09-23 | 2016-08-16 | Bio-Rad Laboratories, Inc. | Calibrations and controls for droplet-based assays |
US9598725B2 (en) | 2010-03-02 | 2017-03-21 | Bio-Rad Laboratories, Inc. | Emulsion chemistry for encapsulated droplets |
US9492797B2 (en) | 2008-09-23 | 2016-11-15 | Bio-Rad Laboratories, Inc. | System for detection of spaced droplets |
US8709762B2 (en) | 2010-03-02 | 2014-04-29 | Bio-Rad Laboratories, Inc. | System for hot-start amplification via a multiple emulsion |
US8663920B2 (en) | 2011-07-29 | 2014-03-04 | Bio-Rad Laboratories, Inc. | Library characterization by digital assay |
US9399215B2 (en) | 2012-04-13 | 2016-07-26 | Bio-Rad Laboratories, Inc. | Sample holder with a well having a wicking promoter |
US9156010B2 (en) | 2008-09-23 | 2015-10-13 | Bio-Rad Laboratories, Inc. | Droplet-based assay system |
US9764322B2 (en) | 2008-09-23 | 2017-09-19 | Bio-Rad Laboratories, Inc. | System for generating droplets with pressure monitoring |
US9132394B2 (en) | 2008-09-23 | 2015-09-15 | Bio-Rad Laboratories, Inc. | System for detection of spaced droplets |
US11130128B2 (en) | 2008-09-23 | 2021-09-28 | Bio-Rad Laboratories, Inc. | Detection method for a target nucleic acid |
US10512910B2 (en) | 2008-09-23 | 2019-12-24 | Bio-Rad Laboratories, Inc. | Droplet-based analysis method |
GB0822260D0 (en) | 2008-12-05 | 2009-01-14 | Merten Christoph | Assay |
GB0822261D0 (en) | 2008-12-05 | 2009-01-14 | Merten Christoph | Assay |
EP3150724A1 (en) | 2008-12-19 | 2017-04-05 | President and Fellows of Harvard College | Particle-assisted nucleic acid sequencing |
CN102341691A (en) | 2008-12-31 | 2012-02-01 | 尹特根埃克斯有限公司 | Instrument with microfluidic chip |
CA2753263A1 (en) | 2009-02-24 | 2010-09-02 | Glaxo Group Limited | Multivalent and/or multispecific rankl-binding constructs |
CA2753332A1 (en) | 2009-02-24 | 2010-09-02 | Glaxo Group Limited | Antigen-binding constructs |
CA2753287A1 (en) | 2009-02-24 | 2010-09-02 | Glaxo Group Limited | Antigen-binding constructs |
EP2406003A2 (en) | 2009-03-13 | 2012-01-18 | President and Fellows of Harvard College | Scale-up of flow-focusing microfluidic devices |
EP2411148B1 (en) | 2009-03-23 | 2018-02-21 | Raindance Technologies, Inc. | Manipulation of microfluidic droplets |
GB0904957D0 (en) | 2009-03-23 | 2009-05-06 | Univ Erasmus Medical Ct | Tumour gene profile |
WO2010117456A2 (en) * | 2009-04-08 | 2010-10-14 | Applied Biosystems, Llc | Column enrichment of pcr beads comprising tethered amplicons |
EP2438154A1 (en) | 2009-06-02 | 2012-04-11 | Integenx Inc. | Fluidic devices with diaphragm valves |
CN102803147B (en) | 2009-06-05 | 2015-11-25 | 尹特根埃克斯有限公司 | Universal sample preparation system and the purposes in integrated analysis system |
JP5099455B2 (en) * | 2009-07-16 | 2012-12-19 | 独立行政法人科学技術振興機構 | Method for selective amplification of RNA using emulsion |
JP5869482B2 (en) | 2009-09-02 | 2016-02-24 | プレジデント アンド フェローズ オブ ハーバード カレッジ | Multiple emulsions produced using jetting and other techniques |
EP2473618B1 (en) | 2009-09-02 | 2015-03-04 | Bio-Rad Laboratories, Inc. | System for mixing fluids by coalescence of multiple emulsions |
EP2720060A1 (en) | 2009-09-28 | 2014-04-16 | Koninklijke Philips N.V. | A biosensor system for single particle detection |
US10520500B2 (en) | 2009-10-09 | 2019-12-31 | Abdeslam El Harrak | Labelled silica-based nanomaterial with enhanced properties and uses thereof |
GB0918564D0 (en) | 2009-10-22 | 2009-12-09 | Plasticell Ltd | Nested cell encapsulation |
AU2010315580B2 (en) | 2009-10-27 | 2014-11-06 | President And Fellows Of Harvard College | Droplet creation techniques |
WO2011056872A2 (en) * | 2009-11-03 | 2011-05-12 | Gen9, Inc. | Methods and microfluidic devices for the manipulation of droplets in high fidelity polynucleotide assembly |
WO2011066185A1 (en) | 2009-11-25 | 2011-06-03 | Gen9, Inc. | Microfluidic devices and methods for gene synthesis |
US8584703B2 (en) | 2009-12-01 | 2013-11-19 | Integenx Inc. | Device with diaphragm valve |
EP2517025B1 (en) | 2009-12-23 | 2019-11-27 | Bio-Rad Laboratories, Inc. | Methods for reducing the exchange of molecules between droplets |
US9399797B2 (en) | 2010-02-12 | 2016-07-26 | Raindance Technologies, Inc. | Digital analyte analysis |
WO2011100604A2 (en) | 2010-02-12 | 2011-08-18 | Raindance Technologies, Inc. | Digital analyte analysis |
US10351905B2 (en) | 2010-02-12 | 2019-07-16 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
US9366632B2 (en) | 2010-02-12 | 2016-06-14 | Raindance Technologies, Inc. | Digital analyte analysis |
EP2550351A4 (en) | 2010-03-25 | 2014-07-09 | Quantalife Inc | Detection system for droplet-based assays |
EP2550528B1 (en) | 2010-03-25 | 2019-09-11 | Bio-Rad Laboratories, Inc. | Droplet generation for droplet-based assays |
US8512538B2 (en) | 2010-05-28 | 2013-08-20 | Integenx Inc. | Capillary electrophoresis device |
WO2012024657A1 (en) | 2010-08-20 | 2012-02-23 | IntegenX, Inc. | Microfluidic devices with mechanically-sealed diaphragm valves |
US9121058B2 (en) | 2010-08-20 | 2015-09-01 | Integenx Inc. | Linear valve arrays |
US9562897B2 (en) | 2010-09-30 | 2017-02-07 | Raindance Technologies, Inc. | Sandwich assays in droplets |
EP4016086A1 (en) | 2010-11-01 | 2022-06-22 | Bio-Rad Laboratories, Inc. | System for forming emulsions |
WO2012069557A1 (en) | 2010-11-24 | 2012-05-31 | Glaxo Group Limited | Multispecific antigen binding proteins targeting hgf |
US9364803B2 (en) | 2011-02-11 | 2016-06-14 | Raindance Technologies, Inc. | Methods for forming mixed droplets |
WO2012112804A1 (en) | 2011-02-18 | 2012-08-23 | Raindance Technoligies, Inc. | Compositions and methods for molecular labeling |
WO2012129187A1 (en) | 2011-03-18 | 2012-09-27 | Bio-Rad Laboratories, Inc. | Multiplexed digital assays with combinatorial use of signals |
AU2012249759A1 (en) | 2011-04-25 | 2013-11-07 | Bio-Rad Laboratories, Inc. | Methods and compositions for nucleic acid analysis |
GB201108259D0 (en) * | 2011-05-17 | 2011-06-29 | Cambridge Entpr Ltd | Gel beads in microfluidic droplets |
EP2714254B1 (en) | 2011-05-23 | 2017-09-06 | President and Fellows of Harvard College | Control of emulsions, including multiple emulsions |
DE202012013668U1 (en) | 2011-06-02 | 2019-04-18 | Raindance Technologies, Inc. | enzyme quantification |
US8841071B2 (en) | 2011-06-02 | 2014-09-23 | Raindance Technologies, Inc. | Sample multiplexing |
CN106518696B (en) | 2011-06-08 | 2019-06-14 | 生命技术公司 | The design and exploitation of novel detergent for PCR system |
US9567628B2 (en) | 2011-06-08 | 2017-02-14 | Life Technologies Corporation | Polymerization of nucleic acids using proteins having low isoelectric points |
JP2014522718A (en) | 2011-07-06 | 2014-09-08 | プレジデント アンド フェローズ オブ ハーバード カレッジ | Multiphase emulsion and method for forming multiphase emulsion |
US8658430B2 (en) | 2011-07-20 | 2014-02-25 | Raindance Technologies, Inc. | Manipulating droplet size |
US10865440B2 (en) | 2011-10-21 | 2020-12-15 | IntegenX, Inc. | Sample preparation, processing and analysis systems |
US20150136604A1 (en) | 2011-10-21 | 2015-05-21 | Integenx Inc. | Sample preparation, processing and analysis systems |
GB201120711D0 (en) | 2011-12-01 | 2012-01-11 | Univ Erasmus Medical Ct | Method for classifying tumour cells |
US9701959B2 (en) | 2012-02-02 | 2017-07-11 | Invenra Inc. | High throughput screen for biologically active polypeptides |
US9701998B2 (en) | 2012-12-14 | 2017-07-11 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10273541B2 (en) | 2012-08-14 | 2019-04-30 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10221442B2 (en) | 2012-08-14 | 2019-03-05 | 10X Genomics, Inc. | Compositions and methods for sample processing |
US9567631B2 (en) | 2012-12-14 | 2017-02-14 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US9951386B2 (en) | 2014-06-26 | 2018-04-24 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10584381B2 (en) | 2012-08-14 | 2020-03-10 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10323279B2 (en) | 2012-08-14 | 2019-06-18 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10752949B2 (en) | 2012-08-14 | 2020-08-25 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US11591637B2 (en) | 2012-08-14 | 2023-02-28 | 10X Genomics, Inc. | Compositions and methods for sample processing |
CA2881685C (en) | 2012-08-14 | 2023-12-05 | 10X Genomics, Inc. | Microcapsule compositions and methods |
US10533221B2 (en) | 2012-12-14 | 2020-01-14 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
CA2900543C (en) | 2013-02-08 | 2023-01-31 | 10X Genomics, Inc. | Partitioning and processing of analytes and other species |
JP6656733B2 (en) | 2013-08-05 | 2020-03-04 | ツイスト バイオサイエンス コーポレーション | Newly synthesized gene library |
US10395758B2 (en) | 2013-08-30 | 2019-08-27 | 10X Genomics, Inc. | Sequencing methods |
CN103487420B (en) * | 2013-09-29 | 2015-08-12 | 浙江大学 | A kind of method preparing microcapsule pH sensor |
US11901041B2 (en) | 2013-10-04 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Digital analysis of nucleic acid modification |
JP6742238B2 (en) | 2013-10-25 | 2020-08-19 | ライフ テクノロジーズ コーポレーション | Novel compounds for use in PCR systems and uses thereof |
WO2015069634A1 (en) | 2013-11-08 | 2015-05-14 | President And Fellows Of Harvard College | Microparticles, methods for their preparation and use |
CN114471756B (en) | 2013-11-18 | 2024-04-16 | 尹特根埃克斯有限公司 | Cartridge and instrument for sample analysis |
US9944977B2 (en) | 2013-12-12 | 2018-04-17 | Raindance Technologies, Inc. | Distinguishing rare variations in a nucleic acid sequence from a sample |
US9824068B2 (en) | 2013-12-16 | 2017-11-21 | 10X Genomics, Inc. | Methods and apparatus for sorting data |
US11193176B2 (en) | 2013-12-31 | 2021-12-07 | Bio-Rad Laboratories, Inc. | Method for detecting and quantifying latent retroviral RNA species |
CN106413896B (en) | 2014-04-10 | 2019-07-05 | 10X基因组学有限公司 | For encapsulating and dividing fluid means, system and method and its application of reagent |
WO2015179098A1 (en) | 2014-05-21 | 2015-11-26 | Integenx Inc. | Fluidic cartridge with valve mechanism |
JP6838969B2 (en) | 2014-06-26 | 2021-03-03 | 10エックス ジェノミクス, インコーポレイテッド | Method for Analyzing Nucleic Acids Derived from Individual Cells or Cell Populations |
CN110211637B (en) | 2014-06-26 | 2023-10-27 | 10X基因组学有限公司 | Method and system for assembling nucleic acid sequences |
KR101776368B1 (en) * | 2014-10-02 | 2017-09-07 | 서울시립대학교 산학협력단 | mRNA nanoparticles and manufacturing method thereof |
EP3209410A4 (en) | 2014-10-22 | 2018-05-02 | IntegenX Inc. | Systems and methods for sample preparation, processing and analysis |
US20160122817A1 (en) | 2014-10-29 | 2016-05-05 | 10X Genomics, Inc. | Methods and compositions for targeted nucleic acid sequencing |
US9975122B2 (en) | 2014-11-05 | 2018-05-22 | 10X Genomics, Inc. | Instrument systems for integrated sample processing |
CN112126675B (en) | 2015-01-12 | 2022-09-09 | 10X基因组学有限公司 | Method and system for preparing nucleic acid sequencing library and library prepared by using same |
SG11201705425SA (en) | 2015-01-13 | 2017-08-30 | 10X Genomics Inc | Systems and methods for visualizing structural variation and phasing information |
US10669304B2 (en) | 2015-02-04 | 2020-06-02 | Twist Bioscience Corporation | Methods and devices for de novo oligonucleic acid assembly |
WO2016126987A1 (en) | 2015-02-04 | 2016-08-11 | Twist Bioscience Corporation | Compositions and methods for synthetic gene assembly |
CA2975529A1 (en) | 2015-02-09 | 2016-08-18 | 10X Genomics, Inc. | Systems and methods for determining structural variation and phasing using variant call data |
EP4286516A3 (en) | 2015-02-24 | 2024-03-06 | 10X Genomics, Inc. | Partition processing methods and systems |
KR20170119710A (en) | 2015-02-24 | 2017-10-27 | 10엑스 제노믹스, 인크. | Targeted nucleic acid sequence coverage method |
WO2016172377A1 (en) | 2015-04-21 | 2016-10-27 | Twist Bioscience Corporation | Devices and methods for oligonucleic acid library synthesis |
US10647981B1 (en) | 2015-09-08 | 2020-05-12 | Bio-Rad Laboratories, Inc. | Nucleic acid library generation methods and compositions |
JP6982362B2 (en) | 2015-09-18 | 2021-12-17 | ツイスト バイオサイエンス コーポレーション | Oligonucleic acid mutant library and its synthesis |
CN108698012A (en) | 2015-09-22 | 2018-10-23 | 特韦斯特生物科学公司 | Flexible substrates for nucleic acid synthesis |
CN108289797B (en) | 2015-10-13 | 2022-01-28 | 哈佛学院院长及董事 | Systems and methods for making and using gel microspheres |
US9895673B2 (en) | 2015-12-01 | 2018-02-20 | Twist Bioscience Corporation | Functionalized surfaces and preparation thereof |
SG11201804086VA (en) | 2015-12-04 | 2018-06-28 | 10X Genomics Inc | Methods and compositions for nucleic acid analysis |
JP6735348B2 (en) | 2016-02-11 | 2020-08-05 | 10エックス ジェノミクス, インコーポレイテッド | Systems, methods and media for de novo assembly of whole genome sequence data |
WO2017197338A1 (en) | 2016-05-13 | 2017-11-16 | 10X Genomics, Inc. | Microfluidic systems and methods of use |
GB2568444A (en) | 2016-08-22 | 2019-05-15 | Twist Bioscience Corp | De novo synthesized nucleic acid libraries |
KR102217487B1 (en) | 2016-09-21 | 2021-02-23 | 트위스트 바이오사이언스 코포레이션 | Nucleic acid-based data storage |
CN110366613A (en) | 2016-12-16 | 2019-10-22 | 特韦斯特生物科学公司 | The Mutant libraries of immunological synapse and its synthesis |
US10815525B2 (en) | 2016-12-22 | 2020-10-27 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10550429B2 (en) | 2016-12-22 | 2020-02-04 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10011872B1 (en) | 2016-12-22 | 2018-07-03 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
WO2018140966A1 (en) | 2017-01-30 | 2018-08-02 | 10X Genomics, Inc. | Methods and systems for droplet-based single cell barcoding |
CA3054303A1 (en) | 2017-02-22 | 2018-08-30 | Twist Bioscience Corporation | Nucleic acid based data storage |
WO2018170169A1 (en) | 2017-03-15 | 2018-09-20 | Twist Bioscience Corporation | Variant libraries of the immunological synapse and synthesis thereof |
GB201707143D0 (en) | 2017-05-04 | 2017-06-21 | Plasticell Ltd | Method for producing cells |
WO2018213774A1 (en) | 2017-05-19 | 2018-11-22 | 10X Genomics, Inc. | Systems and methods for analyzing datasets |
EP4230746A3 (en) | 2017-05-26 | 2023-11-01 | 10X Genomics, Inc. | Single cell analysis of transposase accessible chromatin |
US10844372B2 (en) | 2017-05-26 | 2020-11-24 | 10X Genomics, Inc. | Single cell analysis of transposase accessible chromatin |
WO2018231864A1 (en) | 2017-06-12 | 2018-12-20 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
CA3066744A1 (en) | 2017-06-12 | 2018-12-20 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
SG11202002194UA (en) | 2017-09-11 | 2020-04-29 | Twist Bioscience Corp | Gpcr binding proteins and synthesis thereof |
WO2019079769A1 (en) | 2017-10-20 | 2019-04-25 | Twist Bioscience Corporation | Heated nanowells for polynucleotide synthesis |
SG11201913654QA (en) | 2017-11-15 | 2020-01-30 | 10X Genomics Inc | Functionalized gel beads |
US10829815B2 (en) | 2017-11-17 | 2020-11-10 | 10X Genomics, Inc. | Methods and systems for associating physical and genetic properties of biological particles |
US10936953B2 (en) | 2018-01-04 | 2021-03-02 | Twist Bioscience Corporation | DNA-based digital information storage with sidewall electrodes |
WO2019143622A1 (en) | 2018-01-19 | 2019-07-25 | Bio-Rad Laboratories, Inc. | Mutant dna polymerases |
CN112262218A (en) | 2018-04-06 | 2021-01-22 | 10X基因组学有限公司 | System and method for quality control in single cell processing |
WO2019222706A1 (en) | 2018-05-18 | 2019-11-21 | Twist Bioscience Corporation | Polynucleotides, reagents, and methods for nucleic acid hybridization |
SG11202109322TA (en) | 2019-02-26 | 2021-09-29 | Twist Bioscience Corp | Variant nucleic acid libraries for glp1 receptor |
JP2022522668A (en) | 2019-02-26 | 2022-04-20 | ツイスト バイオサイエンス コーポレーション | Mutant nucleic acid library for antibody optimization |
JP2020143015A (en) * | 2019-03-06 | 2020-09-10 | ソニー株式会社 | Reagent for particle labeling, particle dyeing method, and microscope system |
AU2020298294A1 (en) | 2019-06-21 | 2022-02-17 | Twist Bioscience Corporation | Barcode-based nucleic acid sequence assembly |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4533634A (en) * | 1983-01-26 | 1985-08-06 | Amf Inc. | Tissue culture medium |
US4675285A (en) * | 1984-09-19 | 1987-06-23 | Genetics Institute, Inc. | Method for identification and isolation of DNA encoding a desired protein |
US4801529A (en) * | 1985-06-18 | 1989-01-31 | Brandeis University | Methods for isolating mutant microoganisms using microcapsules coated with indicator material |
GB9107628D0 (en) * | 1991-04-10 | 1991-05-29 | Moonbrook Limited | Preparation of diagnostic agents |
US5177961A (en) * | 1991-06-26 | 1993-01-12 | W. R. Grace & Co.-Conn. | Upstream collimator for electrically heatable catalytic converter |
WO1993003151A1 (en) * | 1991-08-10 | 1993-02-18 | Medical Research Council | Treatment of cell populations |
ATE161964T1 (en) * | 1991-10-15 | 1998-01-15 | Multilyte Ltd | BINDING TEST USING A LABELED REAGENT |
US5270170A (en) * | 1991-10-16 | 1993-12-14 | Affymax Technologies N.V. | Peptide library and screening method |
US5413924A (en) * | 1992-02-13 | 1995-05-09 | Kosak; Kenneth M. | Preparation of wax beads containing a reagent for release by heating |
US5489508A (en) * | 1992-05-13 | 1996-02-06 | University Of Texas System Board Of Regents | Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
DE4223169C1 (en) * | 1992-07-10 | 1993-11-25 | Ferring Arzneimittel Gmbh | Process for the microencapsulation of water-soluble active substances |
US5525504A (en) * | 1993-04-30 | 1996-06-11 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Cytolysin gene and gene product |
JPH09501100A (en) * | 1993-12-30 | 1997-02-04 | エフ エム シー コーポレーション | Water / oil emulsions and water / oil / water emulsions with high internal phase content |
AU710504B2 (en) * | 1994-03-15 | 1999-09-23 | Brown University Research Foundation | Polymeric gene delivery system |
KR19990008000A (en) * | 1995-04-24 | 1999-01-25 | 로버트 에스. 화이트 헤드 | How to create a new metabolic pathway and screen it |
US5989892A (en) * | 1995-06-14 | 1999-11-23 | Tonen Corporation | Microorganisms, demulsifiers and processes for breaking an emulsion |
WO1997012991A1 (en) * | 1995-09-22 | 1997-04-10 | Terragen Diversity Inc. | Method for isolating xylanase gene sequences from soil dna, compositions useful in such method and compositions obtained thereby |
DE19646372C1 (en) * | 1995-11-11 | 1997-06-19 | Evotec Biosystems Gmbh | Conjugates of polypeptide and encoding nucleic acid |
DE19543366C2 (en) * | 1995-11-21 | 1998-09-10 | Stockhausen Chem Fab Gmbh | Water-swellable polymers crosslinked with unsaturated amino alcohols, their preparation and use |
US6011137A (en) * | 1996-04-03 | 2000-01-04 | University Of North Carolina At Chapel Hill | Identification and isolation of novel polypeptides having WW domains and methods of using same |
GB9608540D0 (en) * | 1996-04-25 | 1996-07-03 | Medical Res Council | Isolation of enzymes |
US5876711A (en) * | 1996-05-31 | 1999-03-02 | Onyx Pharmaceuticals, Inc. | Methods and compositions for determining the tumor suppressor status of cells |
IL120466A0 (en) * | 1997-03-17 | 1997-07-13 | Intelligene Ltd | In vitro evolution of oligonucleotides |
US5902727A (en) * | 1996-09-04 | 1999-05-11 | Washington University | Method for localization and quantitation of a substance in a biological sample |
WO1998014592A2 (en) * | 1996-10-01 | 1998-04-09 | Geron Corporation | Telomerase reverse transcriptase |
US6310354B1 (en) * | 1996-12-03 | 2001-10-30 | Erkki Soini | Method and a device for monitoring nucleic acid amplification reactions |
EP1712623B1 (en) * | 1997-01-21 | 2011-10-19 | The General Hospital Corporation | Selection of proteins using RNA-protein fusions |
US6023540A (en) * | 1997-03-14 | 2000-02-08 | Trustees Of Tufts College | Fiber optic sensor with encoded microspheres |
AU6571598A (en) * | 1997-03-18 | 1998-10-12 | Chromaxome Corporation | Methods for screening compounds using encapsulated cells |
US5958738A (en) * | 1997-03-24 | 1999-09-28 | Roche Diagnostics Corporation | Procedure for subtractive hybridization and difference analysis |
US6048551A (en) * | 1997-03-27 | 2000-04-11 | Hilfinger; John M. | Microsphere encapsulation of gene transfer vectors |
EP1002126A4 (en) * | 1997-06-25 | 2004-11-03 | Life Technologies Inc | Improved method for isolating and recovering target dna or rna molecules having a desired nucleotide sequence |
DE69826697T2 (en) * | 1997-07-07 | 2006-02-16 | Medical Research Council | IN VITRO SELECTION METHOD |
US6348278B1 (en) * | 1998-06-09 | 2002-02-19 | Mobil Oil Corporation | Method and system for supplying hydrogen for use in fuel cells |
JP2981547B1 (en) * | 1998-07-02 | 1999-11-22 | 農林水産省食品総合研究所長 | Cross-flow type microchannel device and method for producing or separating emulsion using the device |
GB9900298D0 (en) * | 1999-01-07 | 1999-02-24 | Medical Res Council | Optical sorting method |
CN1189159C (en) * | 2000-05-05 | 2005-02-16 | 欧莱雅 | Micro-capsule contg. water soluble beauty-care activity component water nuclear, and composition contg. same |
GB0022458D0 (en) * | 2000-09-13 | 2000-11-01 | Medical Res Council | Directed evolution method |
US6936264B2 (en) * | 2001-03-05 | 2005-08-30 | The Procter & Gamble Company | Delivery of reactive agents via multiple emulsions for use in shelf stable products |
GB0127564D0 (en) * | 2001-11-16 | 2002-01-09 | Medical Res Council | Emulsion compositions |
WO2004069849A2 (en) * | 2003-01-29 | 2004-08-19 | 454 Corporation | Bead emulsion nucleic acid amplification |
-
1999
- 1999-01-07 GB GBGB9900298.2A patent/GB9900298D0/en not_active Ceased
-
2000
- 2000-01-06 CA CA002479551A patent/CA2479551A1/en not_active Abandoned
- 2000-01-06 DK DK04077799.7T patent/DK1522581T3/en active
- 2000-01-06 DE DE60043289T patent/DE60043289D1/en not_active Expired - Lifetime
- 2000-01-06 AT AT04078076T patent/ATE366307T1/en active
- 2000-01-06 EP EP07013020A patent/EP1905828B1/en not_active Expired - Lifetime
- 2000-01-06 JP JP2000592409A patent/JP4851008B2/en not_active Expired - Lifetime
- 2000-01-06 ES ES00900080T patent/ES2333844T3/en not_active Expired - Lifetime
- 2000-01-06 AU AU18844/00A patent/AU781217B2/en not_active Expired
- 2000-01-06 ES ES04077799T patent/ES2386567T3/en not_active Expired - Lifetime
- 2000-01-06 DE DE60035442T patent/DE60035442T2/en not_active Expired - Lifetime
- 2000-01-06 ES ES07013020T patent/ES2392990T3/en not_active Expired - Lifetime
- 2000-01-06 EP EP00900080A patent/EP1141272B1/en not_active Expired - Lifetime
- 2000-01-06 EP EP04077799A patent/EP1522581B1/en not_active Expired - Lifetime
- 2000-01-06 DK DK00900080.3T patent/DK1141272T3/en active
- 2000-01-06 ES ES04078076T patent/ES2293161T3/en not_active Expired - Lifetime
- 2000-01-06 AT AT00900080T patent/ATE448300T1/en not_active IP Right Cessation
- 2000-01-06 CA CA2357037A patent/CA2357037C/en not_active Expired - Lifetime
- 2000-01-06 WO PCT/GB2000/000030 patent/WO2000040712A1/en active IP Right Grant
- 2000-01-06 EP EP04078076A patent/EP1522582B1/en not_active Expired - Lifetime
- 2000-01-06 CA CA002584933A patent/CA2584933A1/en not_active Abandoned
- 2000-01-06 AT AT04077799T patent/ATE548452T1/en active
-
2001
- 2001-06-29 US US09/896,915 patent/US6808882B2/en not_active Expired - Lifetime
-
2004
- 2004-06-11 US US10/866,237 patent/US20050037392A1/en not_active Abandoned
- 2004-10-01 US US10/956,242 patent/US20050164239A1/en not_active Abandoned
-
2005
- 2005-02-17 JP JP2005041364A patent/JP2005245446A/en not_active Withdrawn
-
2007
- 2007-03-09 JP JP2007060980A patent/JP2007143564A/en active Pending
- 2007-06-18 US US11/820,165 patent/US7897341B2/en not_active Expired - Fee Related
-
2008
- 2008-12-19 US US12/317,123 patent/US20090325236A1/en not_active Abandoned
-
2011
- 2011-02-18 JP JP2011033218A patent/JP5198597B2/en not_active Expired - Lifetime
- 2011-05-11 JP JP2011105768A patent/JP2011206056A/en active Pending
-
2013
- 2013-11-21 US US14/086,787 patent/US20140187762A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2357037A1 (en) | Optical sorting method | |
JP2008515421A5 (en) | ||
US20180208975A1 (en) | Assay for simultaneous genomic and proteomic analysis | |
JP2011092218A5 (en) | ||
Kim et al. | Advances in aptamer screening and small molecule aptasensors | |
CA2295324A1 (en) | In vitro sorting method | |
Wacker et al. | Magneto immuno-PCR: a novel immunoassay based on biogenic magnetosome nanoparticles | |
AU2002310846B2 (en) | Encoded self-assembling chemical libraries (ESACHEL) | |
JP5142290B2 (en) | Method for measuring test substance in sample, aptamer molecule and production method thereof | |
JP2006521922A5 (en) | ||
Diamante et al. | In vitro affinity screening of protein and peptide binders by megavalent bead surface display | |
Li et al. | Fluorescent aptasensors: design strategies and applications in analyzing chemical contamination of food | |
CA2721085A1 (en) | Capture agents and related methods and systems for detecting and/or sorting targets | |
Fan et al. | Aptamer selection express: a novel method for rapid single-step selection and sensing of aptamers | |
Battersby et al. | Optical encoding of microbeads for gene screening: alternatives to microarrays | |
Zhang et al. | Label-free quantifications of multiplexed mycotoxins by G-quadruplex based on photonic barcodes | |
Rozenman et al. | Solving chemical problems through the application of evolutionary principles | |
Brunker et al. | Metallic barcodes for multiplexed bioassays | |
Chern et al. | Transcription Factor Based Small‐Molecule Sensing with a Rapid Cell Phone Enabled Fluorescent Bead Assay | |
Guo et al. | Photoswitch-based fluorescence encoding of microspheres in a limited spectral window for multiplexed detection | |
Lindenburg et al. | Split & mix assembly of DNA libraries for ultrahigh throughput on-bead screening of functional proteins | |
Szeto et al. | Devices and approaches for generating specific high-affinity nucleic acid aptamers | |
Burton et al. | A microfluidic chip-compatible bioassay based on single-molecule detection with high sensitivity and multiplexing | |
CN109716130B (en) | Antigen-coupled hybridization reagents | |
JP2012070654A (en) | Method for producing dna microarray, dna microarray, method for producing protein array, protein array, and method for identifying functional protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20200106 |